Trial intelligence / Profile preview

Long-term follow-up extension of MALARIA-055 PRI malaria vaccine study in African children

PACTR201408000873384Not yet recruiting

Sponsor
GSK
Start
Sep 2014
Countries
3
01

Overview

Trial in malaria (3 arms), sponsored by GSK. Primary endpoint: Occurrence of severe malaria meeting the primary case definition. Planned start Sep 2014; status: not yet recruiting.

02

Conditions

malaria

Beyond the preview

Go deeper on PACTR201408000873384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201408000873384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call